Several hundred NIH employees signed on to a letter rebuking agency actions since the start of President Trump's second term ...

Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...

Fears about the FDA mposing steep barriers to gene therapies for rare diseases appeared moot at an agency roundtable ...

Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...

The Trump executive order is not a pathway to a “gold standard” — it is a blueprint for politicizing science and ...

The Trump administration’s gutting of global aid is threatening to collapse a network of laboratories responsible for global ...

Companies like Sweetgreen, Daily Harvest, and Thrive Market have strong ties to MAHA leaders, including Casey and Calley ...

Four members of the ACIP, which advises the CDC on vaccination policy, have had their status as special government employees ...

Four termination notices and new federal documents. It was a busy weekend for a few STAT reporters. Yesterday, Helen Branswell reported this exclusive: Four out of 19 members of t ...

Budget documents released Friday provide the first clear indication of the priorities of the proposed Administration for a ...

President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...